High rate of recurrence in renal transplant recipients after a first episode of venous thromboembolism

Daniela Poli, Maria Zanazzi, Emilia Antonucci, Rossella Marcucci, Alberto Rosati, Elisabetta Bertoni, Maurizio Salvadori, Agatina Alessandrello Liotta, Rasanna Abbate, Domenico Prisco, Gian Franco Gensini

Research output: Contribution to journalArticlepeer-review


Background. No data are available about the optimal duration of oral anticoagulant therapy (OAT) after an episode of venous thromboembolism (VTE) occurring in renal transplant (RT) recipients. Our study was undertaken to evaluate the risk of VTE recurrence in patients developing a first episode of VTE after RT. Methods. Among 484 RT patients, 34 (7%) developed a first VTE: 28/34 VTE patients (Group 1) were prospectively studied, after stopping OAT. Group 1 was compared with a group of 84 patients without history of renal disease who had suffered from a first episode of VTE matched for age, sex and type of thrombotic event (Group 2) and with a matched group of 84 RT recipients with no history of VTE (Group 3). After OAT withdrawal, blood samples were obtained for thrombophilia and clotting activation markers (prothrombin fragment 1+2 (F1+2) and D-dimer plasma levels). Results. During follow-up, 14/28 patients of Group 1 and 8/84 patients of Group 2 experienced VTE recurrence (P

Original languageEnglish
Pages (from-to)789-793
Number of pages5
Issue number6
Publication statusPublished - Sep 27 2005


  • Oral anticoagulant therapy
  • Renal transplant recipients
  • Venous thromboembolism
  • Venous thromboembolism recurrence

ASJC Scopus subject areas

  • Transplantation
  • Immunology


Dive into the research topics of 'High rate of recurrence in renal transplant recipients after a first episode of venous thromboembolism'. Together they form a unique fingerprint.

Cite this